Growth Hormone Deficiency
By FormBlends Medical Team · Last reviewed April 2026
Adult growth hormone deficiency is a condition in which the pituitary gland produces insufficient growth hormone, leading to changes in body composition, energy, and overall health. GH production naturally declines with age at a rate of roughly 14% per decade after age 30. Growth hormone-releasing peptides offer a way to stimulate the body's own GH production rather than relying on exogenous hormone replacement.
GH production declines roughly 14% per decade after age 30
FormBlends Condition Context
Reviewed May 14, 2026Use Growth Hormone Deficiency condition guide as a decision-support page, not a shortcut. Its job is to connect symptoms and treatment options to a safer provider conversation, especially where the search overlaps with condition-specific care. A useful reader should leave with better questions about clinician oversight, evidence quality, safety limits, cost, pharmacy path, and what changes for their own health history.
- Confirm whether the page is discussing approved care, compounded access, off-label use, or research-only context.
- Check the date, evidence quality, safety limits, and whether newer clinical or regulatory updates may change the answer.
- Ask a licensed clinician how the information applies to your history, medications, labs, goals, and risk profile.
Common Symptoms
- Increased body fat, particularly around the abdomen
- Decreased muscle mass and strength
- Reduced bone density
- Fatigue and reduced exercise capacity
- Poor sleep quality
- Thinning skin and hair
- Elevated cholesterol levels
Common Causes
- Age-related decline in pituitary somatotroph function
- Pituitary tumors or surgery affecting GH-producing cells
- Traumatic brain injury damaging the hypothalamic-pituitary axis
- Radiation therapy to the head or brain
- Idiopathic pituitary insufficiency
Treatment Options
Sermorelin
Sermorelin is a GHRH analog that stimulates the pituitary to release growth hormone in a physiological pulsatile pattern, preserving natural feedback mechanisms.
Learn more about Sermorelin →CJC-1295 / Ipamorelin
This combination activates both the GHRH and ghrelin receptor pathways to maximize growth hormone release while maintaining natural pulsatility and feedback regulation.
Learn more about CJC-1295 / Ipamorelin →MK-677
MK-677 (ibutamoren) is an oral growth hormone secretagogue that stimulates GH release through the ghrelin receptor, increasing IGF-1 levels for up to 24 hours per dose.
Learn more about MK-677 →Tesamorelin
Tesamorelin is an FDA-approved GHRH analog that increases GH production and has been shown to reduce visceral fat while improving lipid profiles.
Learn more about Tesamorelin →Find Treatment for Growth Hormone Deficiency
Browse clinics near you that treat growth hormone deficiency.
Find Clinics